---
title: "Prelude Therapeutics (PRLD.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/PRLD.US/norm.md"
symbol: "PRLD.US"
name: "Prelude Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/PRLD.US.md"
datetime: "2026-05-21T03:10:19.211Z"
locales:
  - [en](https://longbridge.com/en/quote/PRLD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PRLD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PRLD.US/norm.md)
---

# Prelude Therapeutics (PRLD.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1300 | -0.2065 | -0.2591 | -0.4110 | -0.4222 |
| ROE | -64.49% | -103.53% | -117.43% | -139.57% | -109.39% |
| 营业收入 | 4.58M | 5.64M | 6.50M | - | - |
| 净利润 | -10.38M | -16.46M | -19.73M | -31.23M | -32.09M |
| 营业利润 | -14.18M | -16.05M | -20.42M | -32.19M | -34.61M |
| 毛利率 | 100.00% | 100.00% | 100.00% | - | - |
| 净利率 | -226.75% | -291.79% | -303.46% | - | - |
| 利润含金量 | - | -69.41% | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 119.64M | 141.31M | 94.75M | 114.92M | 141.26M |
| 权益乘数 | 1.99 | 2.06 | 1.62 | 1.52 | 1.37 |
| 每股净资产 | 0.9550 | 0.8321 | 0.7688 | 0.9962 | 1.36 |
| 资产周转率 | 0.1282 | 0.0766 | 0.0719 | 0.0413 | 0.0360 |
| 现金及短投 | 81.55M | 103.21M | 54.96M | 73.22M | 99.07M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 31.50M | 32.28M | 33.08M | 33.89M | 34.70M |
| 净债务 | -63.83M | -85.42M | -37.10M | -55.30M | -81.15M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -21.68M | 23.12M | -19.11M | -26.07M | -34.23M |
| 投资现金流 | 8.50M | -60.34M | 40.09M | 11.52M | 62.19M |
| 融资现金流 | -314000.00 | 24.94M | -5000.00 | 37000.00 | -160000.00 |
| 自由现金流 | -18.32M | 27.91M | -12.36M | -15.16M | -24.26M |
| 现金流充裕率 | - | - | - | -35719.18% | -16946.04% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | 0.0000 | 0.0000 | -20000.00 | -47000.00 |